Motivational Interviewing to Increase Postdischarge Antibiotic Adherence in Older Adults with Pneumonia

Consult Pharm. 2016 Jan;31(1):38-43. doi: 10.4140/TCP.n.2016.38.

Abstract

Objective: To evaluate the impact of a pharmacist-led, motivational interviewing on antibiotic adherence following discharge in older adults with pneumonia.

Setting: Inpatient medical wards in a large tertiary academic medical center.

Practice description: Older adults diagnosed with pneumonia were enrolled from December 1, 2013, to August 1, 2014, at Yale-New Haven Hospital.

Practice innovation: Motivational interviewing-a patient-centered method of communication-has gained recognition as a tool that can aid pharmacists in addressing negative health behaviors (e.g., medication adherence, health screenings, substance abuse during counseling sessions). However, the potential role of motivational interviewing in older adults to improve medication adherence during transitions of care is not clear. In this study, in addition to standard discharge care, older adults hospitalized with pneumonia who were randomized to the intervention group received enhanced care: pharmacist-led motivational interviewing.

Main outcome measurements: Evaluation of adherence to prescribed antibiotic regimens and patient satisfaction with the motivational interviewing, enhanced-care session.

Results: Ultimately, 87% of patients in the intervention group (n = 16) compared with 64% of patients in the control group (n = 14) were adherent to their antibiotic regimens. Patient satisfaction with the motivational interviewing intervention was high.

Conclusion: Pharmacist-led motivational interviewing sessions have the potential to positively influence antibiotic adherence rates and patient satisfaction.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Aged
  • Aged, 80 and over
  • Anti-Bacterial Agents / therapeutic use*
  • Female
  • Humans
  • Male
  • Medication Adherence*
  • Motivational Interviewing*
  • Patient Satisfaction
  • Pneumonia / drug therapy*
  • Prospective Studies

Substances

  • Anti-Bacterial Agents